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Abstract
Infectious diarrhoea is a worldwide problem in newborns. Optimal bacterial colonisation may enhance gut maturation and protect against
pathogenic bacteria after birth. We hypothesised that lactic acid bacteria (LAB) administration prevents pathogen-induced diarrhoea in formula-
fed newborns. Newborn caesarean-delivered, colostrum-deprived term piglets on parenteral nutrition for the ﬁrst 15 h, were used as models for
sensitive newborn infants. A commercially available probiotic strain, Lactobacillus paracasei F19 (LAP, 2·6× 108 colony-forming units (CFU)/kg
per d) and a novel LAB isolate, Pediococcus pentosaceus (PEP, 1·3× 1010CFU/kg per d), were administered for 5 d with or without inoculation of
the porcine pathogen, Escherichia coli F18 (F18, 1010 CFU/d). This resulted in six treatment groups: Controls (n 9), LAP (n 10), PEP (n 10),
F18 (n 10), F18–LAP (n 10) and F18–PEP (n 10). The pathogen challenge increased diarrhoea and density of F18 in the intestinal mucosa
(P< 0·05). LAB supplementation further increased the diarrhoea score, relative to F18 alone (P< 0·01). Intestinal structure and permeability were
similar among groups, whereas brush border enzymes were affected in variable intestinal regions with decreased activities in most cases after
F18 and LAB inoculation. Bacterial density in colon mucosa increased after F18 inoculation (P< 0·05) but was unaffected by LAB
supplementation. In colon contents, acetic and butyric acids were increased by PEP (P< 0·05). The LAB used in this study failed to reduce
E. coli-induced diarrhoea in sensitive newborn pigs. In vulnerable newborns there may be a delicate balance among bacterial composition and
load, diet and the host. Caution may be required when administering LAB to compromised newborns suffering from enteric infections.
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Infectious diarrhoea is a severe problem in newborns in many
parts of the world and remains one of the leading causes of
morbidity and mortality in children under 5 years(1,2). Enteric
infections can be caused by various bacteria and viruses,
including enterotoxigenic Escherichia coli (ETEC)(3). ETEC is a
diverse group of pathogens that colonise the small intestine (SI)
in many mammalian species and produce enterotoxins, which
perturbs the intestinal microbiota and stimulates secretion of
electrolytes and water and results in diarrhoea(4). The intestinal
microbiota is increasingly acknowledged as being important for
gut health. A healthy bacterial colonisation may provide a barrier
against pathogens and is important for development and
homoeostasis of the immune system(5,6). Conversely, dysbiosis
and alterations in the composition of the microbiota are asso-
ciated with gastrointestinal diseases such as infectious diarrhoea,
inﬂammatory bowel disease(7) and necrotising enterocolitis
(NEC) in paediatric patients(8).
Following enteric infections in children, probiotics (deﬁned as
‘live microorganisms that confer health beneﬁts to the host when
administered in adequate amounts(9)) have been administered to
restore a healthy and well-balanced microbiota. However, effects
on various patient populations are inconsistent and the optimal
timing, dose and type of probiotics remain unknown. Among the
most commonly used probiotics are lactic acid bacteria (LAB).
A recent systematic review showed that probiotics given to
children with acute gastroenteritis reduced the hospital stay with
Abbreviations: CFU, colony-forming units; CONT, control; ETEC, Escherichia coli; F18, Escherichia coli F18; FISH, ﬂuorescent in situ hybridisation; LAB, lactic
acid bacteria; LAP, Lactobacillus paracasei F19; NEC, necrotising enterocolitis; PEP, Pediococcus pentosaceus; SI, small intestine; qPCR, quantitative PCR.
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1d(10), and probiotics may support resistance against persistent
(>14d) diarrhoea(11). Preventive treatments with probiotics may
also be effective and could potentially support the initial bacterial
colonisation after birth to help establish a well-balanced gut
microbiota within the 1st days or weeks. In turn, such early
treatments may confer a competitive advantage and increase
bacterial tolerance and immune maturation and thereby support
barrier functions against enteric pathogens and their toxins. Fur-
ther, gastric acidity is low in newborns(12) and the pH-reducing
effect of lactic acid, a common LAB metabolite, is one of the ways
whereby probiotics can inhibit growth of potential pathogens(13).
In newborn and newly weaned pigs, infectious diarrhoea is a
common problem in pig herds. Probiotics have successfully
been used as experimental treatments in pig feeds to prevent
this(14–16). Infectious diarrhoea in weaning pigs is often caused
by ETEC such as E. coli F18 (F18)(17). Susceptibility towards F18
depend on the host expression of the FUT-1 gene that is
necessary for the formation of the intestinal F18 receptor(18). We
have recently demonstrated FUT-1 to be expressed in both
preterm and term newborn pigs and documented that F18
inoculation effectively induces diarrhoea already during the ﬁrst
5 d of life in newborn caesarean-delivered and colostrum-
deprived pigs(19,20). Delivery by caesarean section allows a high
degree of standardisation and controlled interventions affecting
the initial bacterial colonisation in the gut. Such pigs are highly
susceptible to enteric and systemic infections because they are
deprived of the passive immunity provided via ingestion of
sow’s colostrum(21). In our model, this sensitivity is further
increased with administration of parenteral nutrition, which is
often a part of the treatment of vulnerable newborn infants. On
this background, we hypothesised that an early postnatal
administration of probiotics would reduce the severity of
F18-induced diarrhoea in newborn, caesarean-delivered,
colostrum-deprived term piglets on parenteral nutrition for the
ﬁrst 15 h. For our studies, we chose to test a relatively well-
known probiotic strain, Lactobacillus paracasei F19 (LAP) and
a probiotic candidate strain, Pediococcus pentosaceus (PEP,
GenBank accession no. JX409638). The LAP strain has been
shown to reduce Clostridium difﬁcile in infants, and diarrhoea
in irritable bowel syndrome patients(22), and it has been shown
to reduce the progression of NEC from stage II (proven NEC) to
stage III (advanced NEC) in preterm infants(23). The PEP strain
was isolated from fermented whey(24). This species has been
granted Qualiﬁed Presumption of Safety status by the European
Food Safety Authority(25), and was initially selected based on its
ability to grow and reduce pH in whey permeate, a well-known
diet supplement in both piglet and paediatric diets(24).
Preliminary studies show that PEP inhibits the growth of several
pathogen indicator strains in vitro (Streptococcus suis, Listeria
monocytogenes, Salmonella typhimurium)(24).
Clinical status in piglets (growth, diarrhoea, blood parameters,
haematology) were assessed together with parameters of intest-
inal structure (villus height, mucosal mass), function (digestive
enzyme activities), intestinal permeability and microbiology
(mucosa-adhering bacteria, bacterial composition, SCFA levels).
These parameters have previously been shown to respond to
probiotic interventions and reﬂect clinical status in newborn
preterm, caesarean-derived, colostrum-deprived pigs(26).
Methods
Preparation of Lactobacillus paracasei F19, Pediococcus
pentosaceus and Escherichia coli F18
The commercially freeze-dried probiotic strain LAP (provided
by Arla Foods Amba) was used by mixing the powder into the
milk replacer at a concentration of 2× 106 colony-forming units
(CFU)/ml. The other strain, PEP, isolated from fermented
whey(24), was freshly grown and harvested around the time of
birth for each litter in the experiment. In brief, PEP from a −80°C
glycerol stock solution was grown in MRS broth (De Man,
Rogosa and Sharpe agar; National Veterinary Institute) and
bacteria were isolated, washed in sterile PBS, resuspended in
the milk replacer (108 CFU/ml) and stored at 4°C. The storage
viability and bacterial concentrations of LAP and PEP were
veriﬁed by daily cultivations of milk samples.
F18 (9910297-2STM, O138:F18(18)) was grown overnight at
37°C on blood agar plates. Approximately 50 µl of colony
material was subsequently suspended in 4ml of sterile PBS and
poured onto an iso-sensitest agar (Oxoid), supplemented with
Alizarin yellow 0·06% w/v (Merck), chosen for optimal
expression of F18 ﬁmbria(27). Excess suspension was discarded
before culturing overnight at 37°C in 10% CO2. The next day,
10ml PBS was poured onto the plate with F18. Bacteria were
gently scraped loose and vortexed into the PBS solution, cor-
responding to approximately 1010 CFU/ml, of which the pigs
received 1ml/d from days 1–4, with the ﬁrst challenge provided
3 h after the initial LAB administration.
Animal protocol and experimental design
All experimental procedures were approved by the National
Ethics Committee on Animal Experimentation (protocol no.
2012-15-2934-00193). Four sows (Danish Landrace× Large
White×Duroc) were selected for homozygosity (M307GG) of
the FUT-1 gene to ensure susceptibility to F18 adhesion and
infection in the offspring(19). A total of sixty-one pigs were
delivered near to term (114 d, term= 116 d) by caesarean
section and piglets were immediately transferred to individual
incubators with heating and O2 supply until euthanasia on
day 5, as described previously(28). One litter (n 12–17) at a time
was reared in the facility where the piglets were stratiﬁed
according to birth weight and sex, and randomly allocated
within each stratum to one of six experimental groups:
untreated controls (CONT, n 9), LAP (n 10), PEP (n 10), F18
(n 10), F18–LAP (n 10) and F18–PEP (n 10). Although still
sedated from the caesarean section, pigs were ﬁtted with
umbilical catheters (infant feeding tube 4 F; Portex) and
oro-gastric feeding tubes (6 F; Portex), both secured to the skin
with sutures. The initial gut colonisation was standardised by
providing a maternal faecal suspension via the feeding tube
(1ml, 2× 107 CFU), followed by a single 1ml bolus of a milk
replacer with no bacteria or containing one of the two LAB
tested (108 CFU) to ensure immediate inoculation of LAB before
full enteral feeding. Parenteral nutrition (7ml/kg per h of
Kabiven, Fresenius Kabi) was given for the ﬁrst 15 h to increase
intestinal sensitivity. To meet piglet nutrient requirements 274 of
1053ml glucose and 80 of 400ml fat was withdrawn, whereas
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140ml sterile water and 214ml Vamin 18 Novum (amino acids;
Fresenius Kabi) was added to reach the following composition:
Energy, 3138 kJ/l; amino acids, 45 g/l; glucose, 72 g/l; lipids,
31 g/l; calcium chloride, 0·21 g/l; sodium glycerophosphate,
1·46 g/l; magnesium sulphate, 0·46 g/l; potassium chloride,
1·75 g/l; sodium acetate, 1·41 g/l. Mother’s plasma was
co-infused (2× 10·5ml/kg) with the parenteral nutrition for
passive immunisation, as described previously(21). From day 2,
parenteral nutrition was discontinued and replaced by full
enteral feedings of 16ml/kg per 3 h. All pigs were given milk
replacer (Milex; Arla Foods), containing additional whey pro-
tein to support normal piglet growth (50 g/l Lacprodan DI-9224;
Arla Foods) to reach the following composition: Energy,
3604 kJ/l; protein, 62 g/l; carbohydrate, 72 g/l; and fat, 37 g/l.
Nutritional intake was adjusted according to body weights
recorded daily together with core body temperatures. Group
diets differed only with respect to addition of the probiotic
bacteria. From day 2, LAB was given via the milk replacer in
daily doses of 2·6× 108 and 1·3× 1010 CFU/kg for LAP and PEP,
respectively. For LAP, the chosen dose was based partly on cost
considerations for commercial use, which prevented supple-
mentation to formula at a dose higher than 108 CFU/kg per day
(discussions with our LAP supplier; Arla Foods). PEP was a new
candidate probiotic, isolated from fermented whey, and a
slightly higher dose was used for PEP to ensure a full response.
The doses for LAP and PEP were both within the range of doses
typically used for probiotic supplementation to formula for
infants (107–1011 CFU/kg per day).
To prevent bacterial cross contamination between the treat-
ment groups, high hygienic standards were maintained at all
times. Incubators from the same treatment groups were clus-
tered together within the experimental unit and feeding was
separated. Diarrhoea was assessed twice a day from day 2 at
09.00 hours to day 5 at 09.00 hours resulting in a total of seven
observations per pig. The following criteria were used to score
the faeces: 0=no faeces, 1= ﬁrm faeces, 2=pasty faeces,
3=droplets of watery faeces/diarrhoea, 4=moderate amounts
of diarrhoea and 5= large amounts of diarrhoea.
Intestinal permeability, organ and tissue sampling
Intestinal permeability was determined as the ratio of lactulose:
mannitol in urine collected at euthanasia on day 5, 3 h after oral
administration (15ml/kg of 5% lactulose and 5% mannitol)(28).
All pigs were fed half a bolus of their normal feed (8ml/kg),
90min before euthanasia to standardise the feeding state of the
collected tissues. Blood was drawn (10ml) by cardiac puncture
into heparin- and EDTA-containing tubes before each piglet
was killed with an intra-cardiac injection of sodium pento-
barbital. Blood samples were immediately analysed for blood
gases, haematocrit, glucose, lactate and pH (GEM Premier 3000;
Instrumentation Laboratory) and blood cells were counted by
an automatic cell counter (ADVIA 2120i; Hematology System).
Internal organs (liver, kidney, lung, heart, spleen, colon and SI)
were immersed in crushed ice, removed and weighed. The SI,
caecum and colon were gently emptied of their contents by
squeezing before weighing and recording of the SI length. On
this basis, the SI was divided into proximal, middle and distal
parts of equal size. Tissues from the middle of all three SI parts
(each 4 cm) together with caecum and colon contents were
collected, snap frozen in N2 and stored at −80°C for analyses of
brush border enzymes (SI tissue), microbiota composition by
high-throughput quantitative PCR (qPCR) analyses (caecum
content) and SCFA concentration (colon contents). Moreover,
sampling of mucosa-associated bacteria was performed. The
most distal 35 cm of the SI was opened longitudinally and gently
scraped with a sterile plastic slide and samples were stored at
−20°C for analyses a few days later by high-throughput qPCR.
Sections of 2 cm from the middle of the proximal, mid and distal
SI and colon was collected and stored in paraformaldehyde for
later histomorphology of SI and ﬂuorescent in situ hybridisation
(FISH) for SI and colon. Finally, mucosa was scraped from
10 cm sections from the last third of both the proximal and the
distal SI and dried at 60°C for 72 h. Dry weight of total tissue and
of mucosa alone was measured to determine the dry weight
proportion of mucosa. To prevent degradation of intestinal
tissue, organs and tissues were kept on a cooling table (2–4°C)
during the entire sampling procedure. All samples were col-
lected within 15min of euthanasia.
Intestinal microbiology
Paraformaldehyde-ﬁxed sections of the proximal, middle and
distal SI and colon were embedded in parafﬁn and sectioned
(3 µm). For each pig, the three SI sections and one section of
colon were mounted on the same glass slide. FISH with oligo-
nucleotide probes 5'-labelled with CY3 (Euroﬁns MWG
Operon) targeting bacterial 16S ribosomal RNA for all bacteria
(S-D-Eub-0338; 5'-GCT GCC TCC CGT AGG AGT-3') was per-
formed. Sections were scanned (ArrayWoRx microarray scan-
ner; Applied Precision to visualise bacterial micro-colonies and
the scanning pictures were used for evaluation of bacterial
abundance. Each tissue section were given a FISH score where
1=no bacteria, 2= few micro-colonies, 3= abundant bacteria
located in the mucosal periphery and 4= extensive colonisa-
tion with bacteria closely associated with the mucosa. The used
method cannot detect bacteria in the mucus layer, as this layer
is not preserved after paraformaldehyde ﬁxation.
Bacterial DNA was extracted from approximately 200mg of
caecum content and mucosal scrapings of distal SI, using the
Maxwell LEV Blood DNA Puriﬁcation Kit (Promega Corpora-
tion), according to the manufacturer’s instructions. This was
performed after an additional pre-treatment with lysozyme for
2 h at 37°C, 2min of bead beating at 20Hz with 5mm steel
beads, and proteinase K treatment for 1 h at 56°C. DNA con-
centration was subsequently quantiﬁed on a NanoDrop
ND-1000 spectrophotometer (NanoDrop Technologies).
Relative bacterial composition of mucosa-associated F18 was
assessed in mucosal scrapings of distal SI by qPCR(29). Caecum
contents and SI mucosa were investigated for relative bacterial
composition using a high-throughput in-house qPCR assay(30).
This assay was set up as a relative 48× 48 dynamic array inte-
grated ﬂuidic circuit system (Fluidigm) using primer sets tar-
geting main phyla and taxonomically related subgroups in the
porcine intestinal microbiota and normalises these against a
primer set speciﬁc for all bacteria(30,31). In all, twenty-two phylo
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groups were included in the assay, as described
previously(30,31), however archae bacteria was replaced by a
primer set targeting the 16S ribosomal DNA gene in PEP
(forward 5'-CTT-CCG-TTA-ATT-GAT-TAT-GAC-3', and reverse
5'-TAT-CAC-TGC-CTT-GGT-GAG-CCT-3').
Microbial metabolic activity was assessed by measuring SCFA
concentrations (mmol/kg wet sample) by GC in samples of
colon contents, as previously described(32).
Intestinal histomorphology and brush border enzymes
The above scanning pictures of paraformaldehyde-ﬁxed sec-
tions of the proximal, middle and distal SI were used for mea-
suring villous heights using the ImageJ Software (version 1.22c
US; National Institute of Health). In all, ten representative villi
were measured in each section, and a mean value was reported.
Samples of the proximal, middle and distal SI were extracted
in 1·0% Triton X-100 and homogenised. Homogenates were
analysed for activities of lactase, sucrase, maltase, aminopepti-
dase N (ApN), aminopeptidase A (ApA) and dipeptidyl
peptidase IV (DPPIV) using lactose, sucrose, maltose, glycyl-L-
proline-4-nitroanilide, L-alanine-4-nitroanilide, and α-L-glutamic
acid 4-nitroanilide, respectively, as substrates and determined
spectrophotometrically as described previously(33).
Statistical analyses
Determination of the sample size for the study population was
based on a power calculation using the estimated mean 88
(SD 12)% (n 43) for F18-induced diarrhoea in previous pig
studies(19,20) and an expected 20% reduction of incidence with
probiotic treatment based on three pig studies where early
probiotic supplementation lead to a 17–26% reduction
of infectious diarrhoea incidence(14–16). Consequently, the
estimated sample size for 90% power was n 10.
Stata 12.0 was used for statistical analyses. Normality of data
was evaluated by the histogram and qnorm command and by
inspection of model residuals. Total leucocytes, lymphocytes
and neutrophils were log transformed before statistical testing.
This was also the case for propionic acid, butyric acid, formic
acid, lactic acid and total SCFA. Group differences in the pre-
valence of diarrhoea were examined using Fisher’s exact test.
The impact of F18 challenge (yes/no) and LAB (LAP, PEP or
NoLAB) was assessed and data were analysed with two-way
ANOVA models adjusted for sex and litter as control variables.
All models included the interaction term F18× LAB. Corre-
spondingly, P values related to the interaction and main effects
of F18 or LAB are from these full models. In cases of signiﬁcant
F18× LAB interaction, differences between treatment groups
were subsequently evaluated using the pwcompare command,
which uses the least signiﬁcant difference method. When no
signiﬁcant interaction but signiﬁcant main effects were found,
these were further investigated using the same method. Bac-
terial phylo group differences, relative to the CONT group, were
assessed using the Mann–Whitney U test. To assess overall
differences in the composition of the microbial communities,
principal component analysis plots based on the presence or
absence of signal in the qPCR analyses from the microbiota
assay were performed using Unscrambler version 9.8 (CAMO).
Values are means with their standard errors, unless otherwise
stated. For all analyses, P< 0·05 was used as the level of sig-
niﬁcance. P< 0·10 was considered as a tendency to a difference
between means.
Results
Of the sixty-one enrolled pigs, ﬁfty-nine completed the study
protocol with two pigs euthanised on day 2 because of the poor
clinical condition (one F18 and one CONT pig). One CONT pig
(11%) had diarrhoea (score≥3) at one observation among the
seven observations with an overall group score of 0·4 (SEM 0·1).
Conversely, 40% (4/10) of the pigs in the F18 group had diar-
rhoea at some point. For three of the pigs this was transient with
only one observation of diarrhoea while the last pig had per-
sistent diarrhoea from day 3 (ﬁve observations). This resulted in
a mean faecal score of 0·8 (SEM 0·3). Despite fewer observations
of diarrhoea in the F18 pigs than expected, a larger proportion
of the faecal scores were categorised as diarrhoea for F18 v.
CONT pigs (P< 0·05, Fig. 1(A)). When administered alone,
neither of the LAB affected diarrhoea scores, compared with
CONT, as no LAP pigs had diarrhoea and one PEP pig (10%)
had diarrhoea for three observations resulting in a group score
of 0·6 (SEM 0·1). On the other hand, when co-inoculated with
F18, LAB signiﬁcantly increased diarrhoea compared with F18
pigs (P< 0·05, Fig. 1(A)). Of the F18–LAP pigs, 40% (4/10) had
ﬁve to six observations of diarrhoea per pig (faecal scores 1·4
(SEM 0·5)) and while 60% (6/10) of the F18–PEP pigs had two to
six diarrhoea observations per pig (faecal scores 1·6 (SEM 0·4)),
with no difference between the two groups (P 0·71).
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All groups had similar birth weights (1249 (SEM 304) g), and
the daily weight gain was similar among treatment groups
(Fig. 1(B)), except for the pigs receiving PEP, where growth
rates were reduced after challenge with F18 (P< 0·05). There
was no difference in body temperature between groups, but
temperatures increased from days 1 to 2 (36·2 (SEM 0·03) v. 38·3
(SEM 0·06)) and remained stable until euthanasia on day 5. By
day 5, the intestinal permeability did not differ between groups
(Fig. 2(A)) and the groups showed similar relative organ
weights (g/kg) for colon (8·0 (SEM 0·2)), lungs (18·4 (SEM 0·8)),
kidneys (7·9 (SEM 0·1)), liver (24·1 (SEM 0·4)), spleen (1·50
(SEM 0·04)) and heart (7·7 (SEM 0·1)). Across all F18-challenged
pigs, the relative SI weight was higher than in non-infected pigs
(37·3 (SEM 0·9) v. 34·2 (SEM 0·6) g/kg, P< 0·01). Values for pH,
pO2, haematocrit, glucose and lactate were similar between
groups (Table 1), whereas values for pCO2 were decreased for
F18 inoculated pigs (Table 1, P< 0·01). Total leucocyte and
neutrophil counts were not affected by treatments (Table 1) but
monocyte and lymphocyte counts were increased across the
F18-challenged pigs, relative to all non-challenged pigs (both
P< 0·05). Further, thrombocyte counts were lower (−20%) in
piglets receiving PEP, alone or in combination with F18, relative
to pigs receiving LAP and NoLAB (Table 1, both P< 0·05).
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F18 challenge reduced the proportion of mucosa in the distal
SI for the LAP pigs (Fig. 2(B)), but otherwise there were no
marked differences in proximal or distal SI mucosal proportions
among groups. Across all groups, the villi were longer in the
middle SI (relative to the proximal and distal regions, P< 0·05),
with no differences between groups for any region. In the distal
SI, F18–PEP pigs had numerically shorter villi than the other
groups (Fig. 2(C)). Fig. 3 shows the enzyme activities in the
proximal, middle and distal SI. Sucrase and maltase activity
were generally highest in the proximal SI while lactase activity
was higher in the proximal and middle SI. Peptidase activities
were similar across all three SI regions. Inoculation with F18
decreased the activity of lactase in the middle and distal SI
(P< 0·001, Fig. 3(I) and (O)), and decreased sucrase activity in
the middle SI (P< 0·05, Fig. 3(G)). Similarly, also ApA and ApN
in the middle and distal SI (P< 0·001, Fig. 3(J), (K), (P), (Q)),
and DPPIV in the distal SI (P< 0·05, Fig. 3(R)) were decreased
following F18 inoculation, whereas maltase activity in the distal
SI was increased (P< 0·05, Fig. 3(N)). LAP and PEP pigs had
lower lactase activity in the proximal SI, compared with pigs not
receiving probiotics (P< 0·05, Fig. 3(C)), and PEP pigs had
lower ApA activity in the middle and distal SI, compared with
pigs not receiving probiotics (P< 0·05, Fig. 3(J) and (P)). On the
other hand, activity for sucrase in the distal SI was higher for
LAP, compared with PEP and pigs not receiving probiotics
(Fig. 3(M)). LAP also increased DPPIV activity in the proximal
SI, compared with PEP (P< 0·05, Fig. 3(F)).
The relative abundance of mucosa-associated F18 bacteria in
the distal SI was 103 times higher in F18-challenged pigs, rela-
tive to non-challenged pigs (P< 0·001), and LAB administration
did not affect the abundance (data not shown). Abundance of
bacterial DNA is relatively low in the distal SI mucosa, relative
to the high amounts of eukaryotic DNA and RNA. This probably
led to the low and variable signals for other bacteria after tissue
DNA extraction, and it was therefore not possible to assess the
effect of LAB or F18 inoculation on these samples. PEP was not
detected in the distal SI mucosa of any PEP-inoculated pigs, but
it was present in the caecum content samples, both with and
without F18 inoculation (P< 0·05 relative to the CONT group,
Fig. 4(a)). For the caecum content samples, the principal com-
ponent analysis plots from the relative microbiota qPCR assay
did not reveal any differences in the bacterial composition
among the treatment groups (data not shown). However, a few
differences were observed in the relative abundances of few
bacterial groups, particularly for pigs administered PEP
(Fig. 4(b)-(h)). Without F18 inoculation, PEP pigs had more
Lactobacillaceae than CONT pigs (P< 0·05, Fig. 4(f)). After F18
inoculation, F18–PEP pigs had more E. coli (P< 0·05, Fig. 4(h))
and tended to have more βγ-proteobacteria (Fig. 4(e)) and
Enterobacteriaceae (Fig. 4(G)), and less Firmicutes (Fig. 4(b))
and Actinobacteria (Fig. 4(d)) than CONT pigs (all P< 0·10).
Neither the LAP nor F18–LAP pigs differed signiﬁcantly from
CONT pigs for any of the bacterial groups. Scanning pictures of
SI and colon tissues (Fig. 5(A) and (B)) showed, as expected,
that the mucus layer had not been preserved during the par-
aformaldehyde ﬁxation. FISH analyses of all bacteria showed
that the bacterial abundance in the proximal, middle and distal
SI mucosa was very low and many sections were negative for
bacteria and it was not possible to assess the effect of LAB or
F18 inoculation. Bacteria were more abundant along the colo-
nic mucosa and pigs challenged with F18 had higher colon
FISH scores than non-challenged pigs (P< 0·001, n 29–30, Fig. 5
(C)). No effect of LAB was observed.
Total SCFA concentration in colon contents was increased by
PEP, compared with LAP (Table 2). Among the SCFA, butyric
and acetic acid concentrations were increased in PEP pigs,
compared with LAP and CONT pigs (all P< 0·05). F18 inocu-
lation speciﬁcally increased succinic acid levels (P< 0·05).
Discussion
Administration of probiotic bacteria just after birth may be an
attractive way to support the initial gut bacterial colonisation
and thereby increase the resistance towards enteric pathogens
in sensitive newborns. In contrast to our hypothesis, we failed
to show that the two LAB strains chosen in this experiment
supported intestinal health in newborn, caesarean-derived,
colostrum-deprived pigs on parenteral nutrition, with or without
administration of ETEC F18. In fact, both the LAP and PEP
supplementations further increased the F18-induced diarrhoea.
In this study, the overall diarrhoea incidence was lower than
that observed in our earlier studies with F18 challenge(19,20) but
overall the data still support that the piglets were clinically
affected by the F18 inoculation, both when given alone and in
combination with LAB. The variation in clinical responses to
F18 challenge among different studies reﬂects the common
difﬁculty in getting consistent pathological response to enteric
pathogen challenge in animal models. The challenge with F18
had limited or no effect on mucosal structure (e.g. proportion of
mucosa, villous height) but the relative SI weight increased,
probably reﬂecting oedema. The negative F18 effects were
supported by decreased lactase and peptidase activities in the
middle and distal SI. The gut microbiota composition was not
markedly affected but F18 challenge increased the total number
of bacteria adhering to the surface epithelium in the colon.
Increased exposure of the gut epithelium to F18 may be related
to the increase in colonic succinic acid level which may or may
not be beneﬁcial for the epithelium(34). The high exposure to
F18 may also induce systemic immune responses, as evidenced
by increased monocyte and lymphocyte counts.
All these seemingly negative effects of F18 challenge were
not prevented by LAB or PEP supplementation to formula. The
presence of PEP bacteria was conﬁrmed in caecum contents of
PEP pigs and the presence of LAP after supplementation has
been studied previously(22). For intestinal enzymatic activities,
we observed no difference or decreases (proximal lactase
activity for LAP and PEP, ApA activity for PEP in the middle and
distal intestine), and only one increase (distal sucrase activity for
LAP). Speciﬁcally for the PEP probiotics, increased nutrient
fermentation was indicated by higher levels of colonic acetic
and butyric acid that may be detrimental for newborns(34). We
observed limited effects on the microbiota composition for both
probiotics although PEP increased the proportion of Lactoba-
cillaceae without F18 inoculation (potentially beneﬁcial), and
increased E. coli after F18 inoculation (potentially negative).
Decreased thrombocyte counts for the PEP group also support
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a potential negative clinical effect. It is not clear if the higher
(50-fold) daily dose of PEP v. LAP played a role for the tendency
to more negative effects of PEP v. LAB for some parameters, but
both strains were given in doses common for infant probiotic
supplementations. We conclude that probiotic bacteria, as
shown by LAP and PEP in this study, should be used with
caution for sensitive newborns during their initial bacterial
colonisation and intestinal immaturity. More studies are
required to show if other doses, or later administration of LAP,
PEP or other probiotic bacteria, induce more favourable effects
in normal and pathogen-challenged newborns.
Our conclusions may be relevant for both pigs and infants.
Still, it cannot be excluded that newborn caesarean-delivered,
colostrum-deprived piglets on parenteral nutrition are more
sensitive to suboptimal diets and enteric infections than normal
newborn infants(21). We have previously shown that F18 chal-
lenge of newborn caesarean-delivered, colostrum-deprived
pigs increases diarrhoea more than in vaginally delivered,
3–20 day-old naturally suckled pigs, despite similar expression
of the receptor required for F18 adhesion in both groups(19).
The sensitivity of the current model may to a large degree
depend on the absence of protective factors in mother’s own
colostrum and milk. Using a similar model, we recently showed
that addition of the human milk oligosaccharide, α1,2-fuco-
syllactose (2'FL) to formula, had limited effects on diarrhoea in
newborn pigs, despite in vitro studies showing reduced
bacterial adhesion to intestinal cells after 2’FL-addition(20). This
suggests that F18 may elicit diarrhoea also without speciﬁc
intestinal adhesion. Nevertheless, in the present study F18
clearly colonised the distal SI mucosa in the F18-challenged
groups, but none of the LAB managed to reduce clinical
symptoms or F18 bacterial adhesion.
In pig farms, probiotics have successfully been given to
pregnant sows(16), newborn pigs(15,16) and weaning piglets(14) to
prevent infectious diarrhoea. These studies showed a
17–26% reduction in diarrhoea prevalence. There are no pre-
vious reports on effects of probiotics in infected, caesarean-
derived, colostrum-deprived newborn pigs on parenteral
nutrition, but older, suckled pigs have been used to assess
probiotic effects upon challenge with ETEC strain E. coli
F4(35–38). Interestingly, Lactobacillus rhamnosus GG (1010CFU/
d) reduced the daily weight gain and tended to increase diar-
rhoea and decrease intestinal villus heights in piglets challenged
with E. coli F4 (a single bolus with 1010CFU of E. coli F4(35)). In
another study, Lactobacillus sobrius (1010–1011 CFU/d) reduced
the pathogen density, but increased diarrhoea in E. coli
F4-inoculated piglets (1010 CFU)(36). When high doses of
L. rhamnosus were compared with moderate doses (1011 v.
109 CFU/d(37), or 1012 v. 1010 CFU/d(38)), both dose regimens
ameliorated the diarrhoea induced by E. coli F4. Still, the higher
doses were associated with more diarrhoea before E. coli F4-
challenge, compared with lower dose(37,38). Both doses of L.
rhamnosus affected leucocyte sub-populations in the lamina
propria and Peyer’s patches and circulating cytokine levels, with
a more proinﬂammatory proﬁle in the pigs given high-dose
probiotics(37,38). The low dose increased the expression of bac-
terial receptors Toll-like receptor (TLR) 2, TLR9 and nucleotide-
binding oligomerization domain-containing protein 1 (NOD1)Ta
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together with TNF-α(38), suggesting doses below 1011CFU/d may
be advantageous(37,38). Increased proinﬂammatory cytokine
responses after administration of the presumed probiotic strain
Pediococcus acidilactici (109 CFU/d) in weaned pigs challenged
with E. coli F4 has been reported(39), but most studies in weaned
pigs have shown positive rather than negative effects of pro-
biotics on growth and infection resistance(35–38).
In clinical practice, the dose chosen for probiotic adminis-
tration will often be based on a combination of factors, for
example biological, practical and commercial considerations. In
the literature, a wide range of doses have been used for various
probiotic strains (107–1012 CFU/d) and generally these doses are
much below the total amount of bacteria in the normal colo-
nised gut (1011–1012 CFU/g intestinal content). Different strains
have different doses for their maximal efﬁcacy and potential
harm. In this study, we chose the doses for LAP and PEP based
on considerations related to both feasibility and presumed
biological response. For the commercially available LAP strain,
its current price only makes a dose of 108 CFU/d feasible for use
in practice. For the less known experimental strain, PEP, we
chose a higher dose (1010 CFU/d), however still within the
range of normal doses for probiotic administration, to better
secure efﬁcacy and colonisation. Ideally, a full range of doses
(107–1010 CFU/d), times of administration after birth, and types
of milk diets should be tested before using probiotic bacteria for
infants. On the other hand, this does not affect our overall
conclusion that probiotics administered in clinically relevant
doses may have adverse effects in immune-compromised
newborn pigs and infants.
An immature intestinal colonisation and immune system of
pigs in this study may explain why introduction of moderate to
high amounts of bacteria with probiotic properties may disturb
a delicate microbial balance and trigger adverse effects. The
parenteral feeding and lack of maternal-derived immunity via
colostrum ingestion further compromises postnatal immunity,
despite that systemic passive immunity was provided via infu-
sion of maternal plasma over the 1st day after birth. In preterm
pigs reared in a similar manner, we have previously shown that
relatively high doses of probiotics (1010–1011 CFU/d), provided
to assist the early gut colonisation during the 1st days after birth,
resulted in either decreased or increased sensitivity to intestinal
inﬂammation, dysfunction and NEC(26,40). Hence, seemingly
beneﬁcial bacteria, or mixtures of bacteria, may under some
circumstances exacerbate intestinal dysfunction when given too
early in too high doses to highly sensitive newborns. The high
bacterial sensitivity of newborn formula-fed pigs is illustrated by
the dramatic NEC-protective effects of delayed gut colonisation
by antibiotics treatment(41) and absence of such symptoms
when rearing preterm pigs in germ-free isolators(20).
Appropriate neonatal gut colonisation is an important
consideration for infants, especially for those born prematurely.
Together, intestinal immaturity, absence of mother’s milk and
the hospital environment may facilitate an adverse bacterial
colonisation that predisposes to intestinal problems and
dys-regulated immunity. Stimulation of gut bacterial colonisa-
tion immediately after preterm birth is controversial and in most
studies, probiotic supplementation does not start until a few
days after birth, together with increasing enteral milk feeding.
Across these studies, probiotics signiﬁcantly reduce NEC risk in
preterm infants(42) but the optimal strain(s), doses and timing
remain unclear. It is possible that beneﬁcial effects predominate
if probiotics are provided in moderate doses (e.g. 108–109
CFU/d), together with mother’s own milk, and that adverse
effects could be observed at higher doses, especially if provided
immediately after birth and together with infant formula(43).
Across the studies in preterm infants, it has been difﬁcult to
show a consistent change in the composition of the gut
microbiota following probiotic administration and this is sup-
ported by the results of this study and with our own studies in
preterm pigs(26,40).
Many factors vary in the studies on probiotic administration in
both newborn infants and animal models, and this makes it
difﬁcult to make ﬁrm conclusions regarding the use of probio-
tics for newborns. Most previous pathogen challenge studies in
animals were not done in newborns and often used lower doses
of pathogens. We deliberately wished to study clinically
relevant endpoints in the naïve, newborn intestine because of
the potential to document a clear effect of adding presumed
beneﬁcial gut bacteria. With or without pathogen challenge, we
could not demonstrate effects of LAB on bacterial density in the
colon mucosa, but some signiﬁcant effects were induced by
PEP for bacterial composition in caecum content and SCFA
levels in colon content (Lactobacillaceae, E. coli, acetic acid,
butyric acid). Clinical endpoints were either not affected, or
showed some negative effects, with the administered LAB. The
total amount of administered microbes, together with bacteria-
speciﬁc epithelial interactions, may be critical factors for the
combined response to probiotics and pathogens in newborns.
Thus, co-inoculation of pathogens and probiotic bacteria may
under certain conditions lead to increased virulence, bacterial
overload, excessive fermentation and diarrhoea in sensitive
newborns(26).
In conclusion, newborn, caesarean-delivered, colostrum-
deprived piglets on parenteral nutrition are highly sensitive to
non-optimal milk diets and gut microbiota manipulations, as
shown in this and other studies(19,20). The tested LAB were
unable to improve clinical symptoms and intestinal indices in
newborn pigs, regardless of F18 challenge. On the contrary, the
LAB interventions appeared to increase the responsiveness to
the ETEC F18. The apparent favourable effects of administering
probiotic bacteria to preterm infants, and in alleviating diar-
rhoea and infections in older children, may partly be explained
by the use of lower doses, later administration, together with
better diets (e.g. mother’s own milk rather than infant formula).
Caution is required when using relatively unknown probiotic
strains, in relatively high doses immediately after birth in
immune-compromised newborns.
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